Home › Funds › Ikarian Capital, LLC › ZURA

Ikarian Capital, LLC position in ZURA

ZURA BIO LTD · Health Care

Ikarian Capital, LLC reported holding 1,018,492 shares of ZURA (ZURA BIO LTD) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.62% of its reported portfolio and ranking #43 among its reported holdings. Ikarian Capital, LLC has disclosed ZURA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.02M sh
Reported value held$4.24M
Portfolio Weight0.62%
First reportedQ3 2025
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's ZURA position evolved

Ikarian Capital, LLC first disclosed a stake in ZURA in Q3 2025 at 2,132,322 shares (US$9.2M). Across 5 filings, Ikarian Capital, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,018,492 shares valued at US$4.2M — a reduction of -200,000 shares quarter over quarter.. Notable position changes include a 62% trim in Q4 2025 (shares rose 14% over the following quarter), a 49% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.13M $9.23M New
Q4 2025 802.32K $4.20M Reduce
Q1 2026 1.19M $7.10M Add
Q2 2026 1.22M $7.19M Add
Q3 2026 1.02M $4.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZURA and 13F data

ZURA (ZURA BIO LTD) is a Health Care company. 42 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$39.3M), Venrock Adviser, LLC (US$26.8M), MPM BioImpact LLC (US$18.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZURA

All ZURA fund holders →

FAQ

How long has Ikarian Capital, LLC held ZURA?

Ikarian Capital, LLC has disclosed ZURA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Ikarian Capital, LLC's current position in ZURA?

As of Q3 2026, Ikarian Capital, LLC holds 1.02M shares of ZURA (ZURA BIO LTD), valued at $4.24M, representing 0.62% of its reported portfolio and ranking #43.

Has Ikarian Capital, LLC been buying or selling ZURA?

In the latest 13F filing (Q3 2026), Ikarian Capital, LLC reduced its position in ZURA.

Which other funds hold ZURA?

Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.